Target intelligence / Profile preview

Splicing factor 3A subunit 3 (SF3A3)

Target
SF3A3
Molecular classification
Other (component of spliceosome; RNA-binding protein)
01

Overview

Splicing factor 3A subunit 3 (SF3A3) is a protein crucial for pre-mRNA splicing, functioning as the third subunit of the SF3A heterotrimeric complex within the U2 small nuclear ribonucleoprotein (snRNP) particle of the spliceosome. It is essential for the conversion of 15S U2 snRNP into the active 17S U2 snRNP, facilitating branch-point recognition and early spliceosome assembly. It contains a zinc finger domain required for interactions within the complex and binds RNA directly. SF3A3 has multiple transcript variants and is involved in additional cellular processes including RNA stabilization, degradation, and possibly direct chromatin interactions. Dysregulation of SF3A3 has been associated with cancer pathogenesis, especially as a modulator of metabolic pathways and cancer stem-like cell phenotypes in contexts such as MYC-driven breast cancer[1][2][3][5][6][7].

Other names
PRP9PRPF9SAP61SF3a60Spliceosome-associated protein 61
02

Biological functions

Pre-mRNA splicingRNA bindingRegulation of gene expressionCell cycle regulation (via indirect effects on TP53 and CDKN1A)
03

Disease associations

Cancer (notably implicated in breast cancer and lung cancer through altered expression and function)Hermansky-Pudlak syndrome 3 (association per genetic mapping)
04

Safety considerations

Disruption of SF3A3 or other spliceosome components can alter splicing fidelity, lead to cell cycle defects, induce TP53-mediated responses, and potentially contribute to oncogenesis or cellular dysfunction[6]
05

Biomarkers

SF3A3 protein levels may serve as a biomarker for molecular and phenotypic features of aggressive human breast cancers[2]

Beyond the preview

Go deeper on Splicing factor 3A subunit 3 (SF3A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splicing factor 3A subunit 3 (SF3A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call